← FDA Drug Approvals (Drugs@FDA)

LISDEXAMFETAMINE DIMESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2024-07-26

Drug application

FDA Application #

ANDA202836

Application type

Abbreviated New Drug Application (Generic)

Brand name

LISDEXAMFETAMINE DIMESYLATE

Generic name

LISDEXAMFETAMINE DIMESYLATE

Active ingredients

LISDEXAMFETAMINE DIMESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2024-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown